Genomic sequences located at the 3' flanking region of the human CD2 gene confer high level tissuespecific, position-independent expression of the gene when introduced in the germ line of mice. In order to further characterize these sequences a range of deletions, from the 3' end were produced and transgenic mice were generated with the human CD2 (hCD2) gene linked to these deleted fragments. This allowed us to establish the minimum sequences necessary for the copy-dependent transgene expression. 2.1 kb or 1.5 kb of 3' flanking sequences linked to a hCD2 mini-gene is sufficient to allow T-cell specific, copy-dependent, integration-independent expression in transgenic mice. 1.1 kb of 3' sequences results in the gene being expressed in a T-cell specific manner, but copy-dependent, integration-independent expression was not observed in a small number of transgenic animals. 0.2 or 0.5 kb of 3' flanking sequences were insufficient to allow expression above the level previously found with a human CD2 gene which lacked 3' flanking sequences. We conclude that the Locus Control Region (LCR) effect is caused by 1.5 kb of flanking sequences immediately 3' to the polyadenylation signal of the gene.
INTRODUCTION
CD2 is one of the earliest markers to appear on the surface of developing thymocytes and in man it is present only on thymocytes and circulating T-cells (1) . In mouse, however, it appears to be present both on T-cells and B-cells (2, 3, 4) . The gene coding for the human CD2 protein has been cloned and is comprised of five exons spanning approximately 15kb of DNA (5) . Transgenic mice carrying the whole of the human gene or a mini gene which lacks all but the first intron, express the gene in a tissue-specific manner at high levels and in a gene copydependent manner (6) . Sequences responsible for this positionindependent expression of the transgene were found within the 3' flanking region of the gene. This locus control region (LCR) was located within a 5.5kb DNA fragment which is hypersensitive to DNasel digestion in thymocytes of transgenic mice. This fragment was also found to be capable of rendering the expression of heterologous genes, such as /3-globin, copy-dependent in the thymus of transgenic mice (6) .
Such properties of genomic DNA have been described in regions of the /3-globin locus (7), the lysozyme gene (8) and the a-globin locus (9) . It is postulated that the function of such sequences is to activate or 'open' the chromatin, a process which is under developmental control. We have analysed the function of these sequences in transgenic mice. This approach allows the control sequences to be exposed to the whole set of developmental events or factors which occur during normal differentiation. Here we present evidence that these locus control sequences are located within 1.5kb downstream of the polyadenylation site of the gene.
MATERIALS
Restriction endonucleases, T4 DNA ligase, Klenow DNA polymerase, SI nuclease, proteinase K, alkaline phosphatase and RNase I were obtained from Boehringer Manheim, Bethesda Research Laboratories, New England Biolabs, Anglian Biotechnology and Sigma Chemical Company. Nitrocellulose filters for Southern and slot-blot analysis were obtained from Schleicher and Schuell. Nylon filters for Northern blot analysis were obtained from Genescreen. Chemicals and other reagents were obtained from BDH, Sigma Chemical Company and Pharmacia. Seaplaque low-gelling temperature agarose was obtained from ICN Biomedicals. Human and murine CD2 cDNA was a gift from Dr. W. A. Sewell (16) . J6 cells is a subclone of the human T-cell line Jurkat.
Generation of 3' flanking region mutants A 2.1 kb Hind III fragment from the 3' flanking region of the hCD2 gene was cloned in Bluescript KS (Stratagene). The 5' Hind HI site of this fragment coincides with the major polyadenylation signal of the gene and is referred to as nucleotide number 1 in the text and in the figures. Sequential deletions from the 3' end of this fragment were generated using Exonuclease HI after digestion of the plasmid with EcoRI and KpnI. Digested plasmid was treated with 10O U Exonuclease HI at 30°C for * To whom correspondence should be addressed 1-5 minutes depending upon the desired extent of digestion. Treated DNA (1.5 ng) was incubated with 0.4 U of SI unclease in a final volume of 150 jd. The ends of the resulting DNA were made blunt using Klenow fragment of DNA polymerase I and 800 ng were recircularized at 16°C for 16 hrs in the presence of 0.4 U of T4 DNA ligase. Transformation of competent E. coli JM109 and isolation of plasmids were performed essentially as described in Ref. 10 .
DNA fragment preparation and microinjection DNA fragments were isolated free from vector sequences essentially as described in ref. 5 . Fertilized oocytes from (CBAXC57BL/10) Fl mice were isolated, and pronuclei were injected with the solution of the isolated DNA fragment at a concentration of 1 -2 /tg/ml of TE buffer (lOmM Tris[pH 7.5], 0.2mM EDTA). Eggs surviving microinjection were transferred into the oviducts of recipient pseudopregnant females (11) .
DNA and RNA extraction and anlysis
Tissues from mice or J6 cells were homogenized in 3M LiCL-6M Urea (12) , and RNA was isolated as described in ref. 5 . DNA was isolated as described before (5) . Total DNA or RNA, (5 micrograms for slot-blot analysis and 10 micrograms for Southern or Northern blot analysis) was immobilized onto nitrocellulose or nylon filters following manufacturers recommendations. Southern blots and Northern blots were hybridized to 32 P labelled probes as described before (13, 14) .
SI nuclease analysis
Total RNA, (10-30 mg), was hybridized with 5' labelled probe (10-30ng) at 52°C in 40mM PIPES (pH 6.4) 400mM NaCl, lmM EDTA and 80% deionized formamide for 14-16 hrs. Samples were digested for 2hrs at 23°C with 100 U of SI nuclease in 200 ml of 200mM NaCl. 30 mM NaOAc (pH 4.8), 2 mM ZnSO4. After phenol extraction and ethanol precipitation, samples were analyzed on a 5% polyacrylamide 8 M urea sequencing gel. The probe used was a 771 bp Bell-Ndel fragment from the 5' end of an artifical hCD2 gene which contained the normal 5' promoter sequences and an intronless gene prepared by D.G. (David Greenberg: Ph.D. Thesis).
RESULTS

Deletion constructs
A CD2 mini gene was constructed by removing the 3' flanking sequences and all but the first intron of the human CD2 gene (6) . The first intron was maintained as evidence exists that not all intronless genes are expressed efficiently in transgenic animals (15) . This mini gene consists of 5.5kb 5' flanking sequences, exon 1, the first intron, fused exons 2 to 5 and 30 base pairs of 3' flanking sequences past the main polyadenylation signal of the human CD2 gene (Fig. IB) . Expression of this mini gene in transgenic animals is very low and non tissue-specific (6) . A similar mini gene construct, however, carrying an additional 5.5kb of 3' flanking sequences was expressed in a positionindependent manner in the thymus of transgenic animals (6) . In order to further characterize these sequences, we performed deletions from the 3' end of this 5.5kb fragment using exom nuclease. The strategy for the generation of the deletion is described in Fig. IB . The first deletion contained only 2.1kb of 3' flanking sequences. This fragment is flanked by two Hindlll sites of which the 5' one coincides with the main polyA addition (Fig. IB) . The resulting plasmid was the basis for the generation of the deletions as described in the Materials and Methods. The length of the remaining DNA after the deletion ranged from 200bp to the full 2.1kb. The deletions were subsequently linked to the CD2 mini gene lacking the LCR described above. Thus, five constructs with varying amounts of 3' flanking sequences were generated ( Fig 1C) . These constructs were microinjected into fertilized mouse eggs and transgenic animals were produced.
Analysis of transgenic mice carrying hCD2 LCR deletion constructs
Nine transgenic mice containing the CD2 mini gene with 2. lkb 3' flanking sequences were analysed, as follows. DNA slot and southern blot analysis showed that the transgenic mice contained a number of transgene copies from low, such as mice CD2 [ Fig. 2a) . Total RNA was isolated from the thymus (Fig. 2a ) and other tissues (data not shown) and was immobilized on nitrocellulose filters. The filters were subsequently hybridized to hCD2 cDNA radiolabelled probe. Gene copy number analysis and the corresponding level of RNA expression in transgenic thymuses is shown in Fig. 2a . The filters were hybridized to murine CD2 cDNA probe to indicate the amount of DNA or RNA loaded in each slot. Taking into account the amounts of DNA and RNA loaded, this figure shows that the level of the transgene expression in the thymus of the majority of the transgenic animals corresponds to the gene copy number which is indicated in the DNA slot blot. One exception does occur in mouse CD2[2.1].7 which, upon Southern blot analysis of DNA digested with Bglll, was shown to have a proportion (approx. 40%) of the human CD2 gene in a rearranged form (data not shown). The RNA levels detected in the thymus of this transgenic mouse are lower than the gene copy number would indicate, presumably because the rearrangements of the transgene affected expression.
The rest of the deletions were analyzed in a similar manner. Fig. 2b shows the DNA and thymus RNA analysis of eleven transgenic mice carrying the hCD2 mini gene with 1.5kb of 3' flanking sequences. All animals in this series show that the expression of the transgene in the thymus is copy-dependent and position-independent. Southern blot analysis revealed that the transgene was intact in all of these mice (data not shown). Fig. 2c shows the analysis of 18 transgenic mice carrying a hCD2 mini gene with 1. lkb of 3' flanking sequences. Fourteen of these mice expressed the transgene in the thymus in high levels and in a copy dependent manner. In three cases, however, CD2 [1.1] .3, CD2[1.1].5 and CD2[1.1].13, the expression did not match the number of the integrated transgene copies. Southern blot analysis of DNA from these transgenic mice did not reveal any rearrangements or deletions that could be detected by this technique (data not shown). Fig. 2d shows the analysis of three transgenic mice carrying a hDC2 mini gene with 0.5kb of 3' flanking sequences. Despite the fact that the copy number content varies from 1 to 20 copies, we could detect low or no expression of CD2 in the thymus from these mice. Similarly, four transgenic mice carrying varying copy numbers of a hCD2 mini gene with .2kb 3' flanking sequences, showed no or minimal expression of CD2 mRNA in their thymuses (Fig 2e) .
RNA analysis from non lymphoid tissues of all of the mice mentioned above showed no expression of hCD2 (data not shown). A representative Southern blot analysis of DNA from transgenic mice carrying deleted constructs is shown in figure 3 .
The CD2 mini gene directs the expression of proper transcripts
In order to ascertain that deletions at the 3' flanking region of the mini gene did not affect transcription qualitatively, Northern blot analysis of the RNA produced in the thymuses of all the founder transgenic animals was performed. Fig. 4A shows a representative thymus mRNA sample from mice carrying each of the deleted constructs blotted from an agarose gel and hybridized to human CD2 sequences. In total RNA from the human cell line J6 or the thymus of transgenic mice carrying the full hCD2 gene, including all five exons and four introns, the probe hybridises to two mRNA species, 1.7 and 1.5kb (16) . Transgenic mice carrying the mini gene, however, express only the larger species of mRNA. This is probably due to the tertiary structure of the primary transcript, which may not allow usage of the upstream polyA signal which gives rise to the smaller mRNA species. This Northern blot indicates that the deletions have no effect on the size of the mRNA.
SI nuclease analysis of RNA from thymuses of mice carrying an unmodified CD2 mini gene and mice carrying the deleted mutants also showed that transcription initiation from these constructs was not affected. Figure 4C shows a representative experiment comparing transcription initiation from transgenic mice carrying an intact mini gene and mice carrying a mini gene with 1.1 kb only of 3' flanking sequences. The difference observed between initiation in transgenic thymocytes and human J6 T-cell line has been seen in other systems. Different cap sites of the same gene are used preferentially by normal cells and transgenic cells. Thus, a Thy-1 transgene uses different cap sites in the brain compared to the endogenous gene (17) . The significance of this difference is unclear at the moment.
DISCUSSION
The 3' flanking sequences of the human CD2 gene contain a region which behaves like a locus control region (LCR). It confers copy-dependent position-independent expression on the CD2 gene as well as on heterologous genes in the thymus of transgenic animals. Previously these sequences had been located in a 5.5kb fragment immediately downstream from the polyadenylation site of the gene. In this report we present evidence that the important sequences for position-independent expression are located more precisely between 500 and 1500bp downstream from the polyadenylation signal. Deletion mutants which had progressively less 3' flanking sequences were generated. Transgenic mice carrying these deleted constructs showed that 1.5kb of the 3' flanking region are sufficient to exert the LCR effect in the thymus of these mice. Animals carrying 500bp or less of 3' flanking sequences express the transgene at very low levels or not at all. Thus, we conclude that in the 500bp deletion mutant we had removed the sequences necessary for the locus control effect. The expression pattern in transgenic animals carrying the CD2 mini gene plus 1. lkb 3' flanking sequences is more complicated. The majority of the mice express the transgene in a gene copy dependent manner in their thymuses. However, in a small number of cases the expression of the transgene, although still tissuespecific, did not correspond to the number of copies integrated in the genome. Southern blot analysis revealed that there were no rearrangements of the integrated copies.
Since these mice were all founder mice, it is possible that some of them were mosaic for the transgene. Therefore, DNA from tissues other than spleen (and in the case of CD2 [ 1.1 ]. 3 also from thymus) was analyzed for transgene copy number (data not shown). No mosaicism was detected however. A further possible reason for a reduction of gene expression is X-inactivation. This could be the case for one female animal CD2[1.1].3, but the other mice CD2[1.1].5 and CD2[1.1]13 were male. Finally, it is possible, but unlikely, that in these three animals integration occurred at a chromatin locus the activation of which would be incompatible with T-cell viability, therefore the transgene expression is suppressed. Thus, at present we cannot determine whether the aberrant expression in these three transgenic mice is due to an artifact or due to removal of important sequences which render the construct more sensitive to position effects.
Very little expression was observed with constructs containing 500bp or less of the 3' flanking sequences. These results suggest that a relatively small region of 3 human flanking sequences (1.5kb) is able to confer tissue-specific, copy-dependent, integration-independent expression of the human CD2 gene. Sequences that confer such properties have been associated with DNasel hypersensitive sites in the chromatin of expressing cells. Within the human CD2 locus one hypersensitive site (site 1) was positioned immediately 5' of the first exon within the promoter of the gene (Fig. 1A) . Two further sites were found approximately 0.5kb (site 2) and 1.0 to 1.5kb (site 3) 3' of the polyadenylation signal of the gene (6) . Site 2 is a strong DNasel hypersensitive site, whereas site 3 is comparatively weak. The 5' flanking sequences of the CD2 gene and, therefore, DNasel hypersensitive site 1 were maintained in all cases in this report. Mice carrying the CD2[2.1] and the CD2 [1.5] transgenes also contained regions covering both sites 2 and 3. Mice containing construct CD2 [1.1] include DNasel hypersensitive site 2, however, it is uncertain at the moment whether they include DNasel hypersensitive site 3. Therefore the correlation between the 3' hypersensitive sites and the expression of the human CD2 transgene is strong and resembles the correlation found in the /3-globin locus (18) . Hypersensitive site 2 appears to be associated with a strong transcriptional enhancer, as determined by transient expression experiments using chloramphenicol acetyl transferase (CAT) as a reporter gene (19) . We are currently investigating whether this transcriptional enhancer alone is sufficient to confer position independent expression on the hCD2 transgene.
In order to identify potential binding sites of regulatory transcription factors within this region a computer homology search was performed. In the past few years rapid progress has been made in the field of T-cell specific transcription. Several transcription factors, that are uniquely expressed in T-lymphoid cells, have been isolated and cloned. Two of these factors, Tcell transcription factor 1 (TCF 1) (20) and T-cell transcription factor 1 (TCF 1) (21), have been shown to be members of the HMG family of transcription factors and the third GATA 3 is a member of the zinc finger GATA binding family (22, 23) .
The binding site of TCF 1 has been well characterized. The factor has been shown to bind to a core sequence of CTNTG in the a TCR enhancer, where N is either a T, C or G residue. This motif is found in a number of other T-cell promoters and enhancers some of which have been shown to bind TCF 1 with high affinity.
A second T-cell specific transcription factor, TCF 1, binds to the CD3 e 3' enhancer. Methylation interference footprinting has shown that the protein binds to the sequence AACAAAG. This sequence has not been found in other T-cell specific enhancers but a number of authors have pointed out that the complementary strand of this sequence is CTTTGTT which contains the TCF 1 CTNTG binding site.
GATA 3 is a member of the rapidly expanding family of G-ATA binding proteins. GATA 3 has been shown to bind to the TCR 5 gene enhancer and the TCR a gene enhancer. The consensus binding sequence is WGATAR (W = T or A, R = G or A).
Within the 2kb 3' flanking sequences of the human CD2 gene there are a number of sites which contain the TCF 1 a binding site consensus sequence. Interestingly, clusters of these possible binding sites are found in regions where hypersensitive sites have been mapped (Fig. 5) .
Several GATA binding sites are also present in the CD2 3' region. Homology to Ets (24) and Elf binding sites were also observed within the 2 kb 3' fragment (Fig. 5) . Several other partial homologies to other known T-cell enhancers included the sequence motif AGAGAGAGACAGAGA found in the purine rich 3' enhancer of the murine and human CD3 5 genes and also in the promoter areas of these genes (25) . A partial match to this sequence was found within the human CD2 3' flanking region at 1.1 to 1.2kb 3' to the polyadenylation signal, namely AGA-GAGAGAGAGAGA, the mismatched base being underlined. Three further regions of sequences were found to be partially homologous to the murine and human CD3 8 enhancer elements: TTTCTTCTACTTCGT6 TTTCTTCT human CD2 and GTGTGGCAAGCACC CD35 TGTGGCACGCACC hCD2.
Further searches identified homologies with B cell factor binding sequences, namely, to an NF-/tE3 binding immunoglobulin heavy chain enhancer sequence 'GTCATGTGGCAAG 13 in that bases 3 to 11 correspond to the sequence CATGTGGCA found at lkb downstream from the polyadenylation signal of the hCD2 gene (for review see ref. 26) . Assigning any in vivo role to these putative binding sites requires further functional analysis, as well as in vitro footprinting and binding experiments.
